Skip to content
OpenCapital
Get started

Bio-Rad Laboratories, Inc. BIO.B Effect of currency exchange rate changes on cash, cash equivalents, and restricted cash

Effect of currency exchange rate changes on cash, cash equivalents, and restricted cash at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
——

Other financials

Income statement

See full
Revenue$592.1M+1.1%
Gross profit$309.4M+1.1%
Operating income$34.1M+43.9%
Net income-$527.1M-924%
EPS (diluted)-$19.55-954%

Balance sheet

See full
Cash & equivalents$509.0M-2.7%
Total debt$987.3M-28.4%
Total equity$6.9B+2.6%
Total assets$9.8B+2.8%

Cash flow

See full
Operating cash flow$108.1M-16.8%
CapEx$30.0M-12.8%
Free cash flow$78.1M-18.2%

Valuation

See full
Market cap$7.56B+10.3%
Enterprise value$8.04B+4.2%
P/E44.8×—
P/S2.9×+0.2×

Profitability

See full
Gross margin51.9%-1.6pp
Operating margin8.8%-3.1pp
Net margin6.5%+3.4pp
FCF margin13.8%-0.2pp

Returns & leverage

See full
Return on equity2.5%+1.3pp
Debt / equity0.1×-0.1×
Current ratio3.2×-2.8×

Where this comes from

Reported directly by Bio-Rad Laboratories, Inc. in its filing.

Tagged under the XBRL concept us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations.

The official record: Bio-Rad Laboratories, Inc.’s 10-K, filed February 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bio-Rad Laboratories, Inc.'s effect of currency exchange rate changes on cash, cash equivalents, and restricted cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bio-Rad Laboratories, Inc.'s effect of currency exchange rate changes on cash, cash equivalents, and restricted cash?
Bio-Rad Laboratories, Inc. (BIO.B) reported effect of currency exchange rate changes on cash, cash equivalents, and restricted cash of -$4.23M in Q4 2025.
How has Bio-Rad Laboratories, Inc.'s effect of currency exchange rate changes on cash, cash equivalents, and restricted cash changed year-over-year?
Bio-Rad Laboratories, Inc.'s effect of currency exchange rate changes on cash, cash equivalents, and restricted cash decreased by 283.7% year-over-year, from $2.3M to -$4.23M.
What is the long-term trend for Bio-Rad Laboratories, Inc.'s effect of currency exchange rate changes on cash, cash equivalents, and restricted cash?
Over 4 years (2021 to 2025), Bio-Rad Laboratories, Inc.'s effect of currency exchange rate changes on cash, cash equivalents, and restricted cash has grown at a 7.5% compound annual growth rate (CAGR), from -$12.64M to -$16.9M.